Serum interleukin 10 in early stage multiple myeloma

This publication has 9 references indexed in Scilit:

• Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.
  Proceedings of the National Academy of Sciences, 1992
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
  The Journal of Experimental Medicine, 1991
• Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
  Blood, 1991
• Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.
  Proceedings of the National Academy of Sciences, 1991
• Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10
  International Immunology, 1990
• Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.
  Journal of Clinical Investigation, 1989
• Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6
  Blood, 1989
• Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
  Nature, 1988
• A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
  Cancer, 1975